Back
Entrada Therapeutics Stock Price Chart
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Buy
79
TRDA
Entrada Therapeutics
Last Price:
19.81
Seasonality Move:
-35.78%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRDA is experiencing slight selling pressure.
Entrada Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.21 | Buy |
| 20-day SMA: | 18.03 | Buy |
| 50-day SMA: | 16.58 | Buy |
| 200-day SMA: | 15.09 | Buy |
| 8-day EMA: | 19.25 | Buy |
| 20-day EMA: | 18.29 | Buy |
| 50-day EMA: | 17.2 | Buy |
| 200-day EMA: | 15.71 | Buy |
Entrada Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.89 | Buy |
| Relative Strength Index (14 RSI): | 76.13 | Buy |
| Chaikin Money Flow: | -47207 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.65 - 18.93) | Buy |
| Bollinger Bands (100): | (14.78 - 17.7) | Buy |
Entrada Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Entrada Therapeutics Stock
Is Entrada Therapeutics Stock a Buy?
- Entrada Therapeutics share price is 19.98 while TRDA 8-day simple moving average is 19.21, which is a Buy signal.
- The stock price of TRDA is 19.98 while Entrada Therapeutics 20-day SMA is 18.03, which makes it a Buy.
- Entrada Therapeutics 50-day simple moving average is 16.58 while TRDA share price is 19.98, making it a Buy technically.
- TRDA stock price is 19.98 and Entrada Therapeutics 200-day simple moving average is 15.09, creating a Buy signal.
TRDA Technical Analysis vs Fundamental Analysis
Buy
79
Entrada Therapeutics (TRDA)
is a Buy
Is Entrada Therapeutics a Buy or a Sell?
-
Entrada Therapeutics stock is rated a Buy
The current Entrada Therapeutics [TRDA] share price is $19.98. The Score for TRDA is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
Entrada Therapeutics Stock Info
Market Cap:
747.18M
Price in USD:
19.98
Share Volume:
219.66K
Entrada Therapeutics 52-Week Range
52-Week High:
20.21
52-Week Low:
10.75
Buy
79
Entrada Therapeutics (TRDA)
is a Buy
Entrada Therapeutics Share Price Forecast
-
What is the Entrada Therapeutics stock price today?
The Entrada Therapeutics stock price is 19.98 USD today. -
Will TRDA stock go up or go down?
Entrada Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Entrada Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Entrada Therapeutics is not overvalued.
Is Entrada Therapeutics Stock a Buy?
- Entrada Therapeutics share price is 19.98 while TRDA 8-day exponential moving average is 19.25, which is a Buy signal.
- The stock price of TRDA is 19.98 while Entrada Therapeutics 20-day EMA is 18.29, which makes it a Buy.
- Entrada Therapeutics 50-day exponential moving average is 17.20 while TRDA share price is 19.98, making it a Buy technically.
- TRDA stock price is 19.98 and Entrada Therapeutics 200-day simple moving average is 15.71, creating a Buy signal.
Fundamental Analysis of Entrada Therapeutics
Is Entrada Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.09 per share, and a decrease next year of $4.11 per share.
Technical Analysis of Entrada Therapeutics
Should I short Entrada Therapeutics stock?
- TRDA Moving Average Covergence Divergence (MACD) indicator is 0.89, suggesting Entrada Therapeutics is a Buy
- Entrada Therapeutics Relative Strength Index (RSI) is 76.13, which suggest Entrada Therapeutics is overbought
- The Bollinger Bands (25) for Entrada Therapeutics is (16.65 - 18.93), which suggest Entrada Therapeutics is a Buy
- The Bollinger Bands (100) for Entrada Therapeutics is (14.78 - 17.7), which suggest Entrada Therapeutics is a Buy
* Entrada Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.